Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.08B |
| Enterprise Value | 4.98B |
| P/E Ratio | 10.64 |
| PEG Ratio | -0.94 |
| Price/Sales Ratio | 2.98 |
| Price/Book Ratio | 1.22 |
| Enterprise/Revenue | 1.75 |
| Enterprise/EBITDA | 4.84 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.28 |
| Operating Margin | 0.32 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 1.51B |
| Revenue/Share | 1.98 |
| Gross Profit | 925.58M |
| EBITDA | 495.52M |
| Net Income | 397.22M |
| Diluted EPS | 0.47 |
Balance Sheet
| Total Cash | 2.21B |
| Total Cash/Share | 2.64 |
| Total Debt | 125.8M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 21.03 |
| Book Value Per Share | 5.06 |
Price History
| 52-Week Change | -36.54 |
| 52-Week High | 9.5 |
| 52-Week Low | 5.81 |
| Moving Average 50 Days | 6.53 |
| Moving Average 200 Days | 7.65 |
Statistics
| Average Volume | 883,719 |
| Shares Outstanding | 837.1M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 6.79 |
| Payout Ratio | 1.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
